Literature DB >> 25973134

Inhibition of ovarian cancer proliferation and invasion by pachymic acid.

Ai-Hua Gao1, Liang Zhang2, Xin Chen1, Ying Chen1, Zhen-Zhen Xu1, Ya-Nan Liu1, Hong Zhang1.   

Abstract

To determine the effect of pachymic acid (PA) on proliferation, cell cycle, and invasion in human ovarian carcinoma cell lines HO-8910 and explore some possible mechanisms, HO-8910 cells was treated with different concentrations of PA (0.5, 1, 2 μM). CCK-8 assay, propidium iodide staining, was applied to measuring the growth inhibiting rates of HO-8910 cells. Cell cycle was measured by flow cytometry. In addition, the activity of PA against HO-8910 cells invasion was evaluated in transwell assay. Western blot detected the proteins expression of E-cadherin, β-catenin and COX-2 of different groups treated with PA in different concentrations (0.5, 1, 2 μM) for 48 h. Our results showed that PA could effectively inhibit the in vitro growth of HO-8910 cells in dose-dependent manners in 72 h, suppressed migration and invasion of HO-8910 cells in concentration-dependent manners at 24 h, caused the increased accumulation of G1 phase cells, and caused down-regulation of β-catenin and COX-2 and up-regulation of E-cadherin expression level. Taken together, it could conclude that PA might inhibit proliferation and invasion of ovarian carcinoma cell through decreasing β-catenin and COX-2 expression and increasing E-cadherin expression.

Entities:  

Keywords:  HO-8910 cells; invasion; pachymic acid; proliferation

Mesh:

Substances:

Year:  2015        PMID: 25973134      PMCID: PMC4396302     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  Connecting COX-2 and Wnt in cancer.

Authors:  F Gregory Buchanan; Raymond N DuBois
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 31.743

2.  Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation.

Authors:  Yu-Chuan Huang; Wen-Liang Chang; Su-Fen Huang; Cheng-Yu Lin; Hang-Ching Lin; Tsu-Chung Chang
Journal:  Eur J Pharmacol       Date:  2010-09-09       Impact factor: 4.432

3.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

4.  Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos.

Authors:  Leslie Gapter; Zaisen Wang; Jan Glinski; Ka-yun Ng
Journal:  Biochem Biophys Res Commun       Date:  2005-07-15       Impact factor: 3.575

Review 5.  beta-Catenin signaling: therapeutic strategies in oncology.

Authors:  Han Li; Rifat Pamukcu; W Joseph Thompson
Journal:  Cancer Biol Ther       Date:  2002 Nov-Dec       Impact factor: 4.742

Review 6.  Wnt signaling in ovarian tumorigenesis.

Authors:  T A Gatcliffe; B J Monk; K Planutis; R F Holcombe
Journal:  Int J Gynecol Cancer       Date:  2007-11-06       Impact factor: 3.437

7.  Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer.

Authors:  Levon Badiglian Filho; Celina Tizuko Fujiyama Oshima; Flávio De Oliveira Lima; Henrique De Oliveira Costa; Robério De Sousa Damião; Thiago Simão Gomes; Wagner José Gonçalves
Journal:  Oncol Rep       Date:  2009-02       Impact factor: 3.906

8.  Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

Authors:  Kenjiro Sawada; Anirban K Mitra; A Reza Radjabi; Vinay Bhaskar; Emily O Kistner; Maria Tretiakova; Sujatha Jagadeeswaran; Anthony Montag; Amy Becker; Hilary A Kenny; Marcus E Peter; Vanitha Ramakrishnan; S Diane Yamada; Ernst Lengyel
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

9.  The prognostic significance of COX-2 and survivin expression in ovarian cancer.

Authors:  Pauline Athanassiadou; Dimitra Grapsa; Peter Athanassiades; Maria Gonidi; Anna-Maria Athanassiadou; Angelos Tsipis; Efstratios Patsouris
Journal:  Pathol Res Pract       Date:  2008-01-02       Impact factor: 3.250

10.  Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.

Authors:  G Ferrandina; L Lauriola; G F Zannoni; A Fagotti; F Fanfani; F Legge; N Maggiano; M Gessi; S Mancuso; F O Ranelletti; G Scambia
Journal:  Ann Oncol       Date:  2002-08       Impact factor: 32.976

View more
  3 in total

1.  Comparison of the effects of pachymic acid, moronic acid and hydrocortisone on the polysome loading of RNAs in lipopolysaccharide-treated THP-1 macrophages.

Authors:  Tomohito Kakegawa; Lucia Satiko Yoshida; Mariko Takada; Mari Noguchi; Ken Yasukawa; Hiromi Takano-Ohmuro
Journal:  J Nat Med       Date:  2018-11-09       Impact factor: 2.343

Review 2.  Pharmacological profiles and therapeutic applications of pachymic acid (Review).

Authors:  Chunyong Wei; Hezhen Wang; Xun Sun; Zhixun Bai; Jing Wang; Guohui Bai; Qizheng Yao; Yingshu Xu; Lei Zhang
Journal:  Exp Ther Med       Date:  2022-07-01       Impact factor: 2.751

Review 3.  Multifunctional Actions of Ninjinyoeito, a Japanese Kampo Medicine: Accumulated Scientific Evidence Based on Experiments With Cells and Animal Models, and Clinical Studies.

Authors:  Kanako Miyano; Miki Nonaka; Miaki Uzu; Kaori Ohshima; Yasuhito Uezono
Journal:  Front Nutr       Date:  2018-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.